Enzaplatovir
Enzaplatovir (BTA-585) is an orally available fusion inhibitor with antiviral activity for the study of respiratory syncytial virus infections and coronavirus disease (COVID-19) infections.
Product Specifications
CAS Number
1323077-89-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
377.4
Molecular Formula
C20H19N5O3
Notes
Research use only, not for human use.
Receptor
RSV
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP86735_P050 100 µL
TUBB2A Antibody - N-terminal region (ARP86735_P050)
Sign In for Pricing
View Details 
VAng-Lsx6766-500gEcoli 500 µg (E. coli)
Recombinant Chlamydophila Trachomatis hemH Protein (aa 1-314) (strain D/UW-3/Cx)
Sign In for Pricing
View Details K0815207 1.0 µg DNA
FRS2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
K4768008 1.0 µg DNA
Ttc4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details